Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
The TYSABRI Global Observational Program in Safety (TYGRIS) is a safety observational cohort program designed to obtain long-term safety data in multiple sclerosis (MS) participants treated with natalizumab in a clinical practice setting in the United States or Canada.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
MS patients in the US and Canada receiving TYSABRI under standard clinical care for less than or equal to 3 infusions are eligible to participate in TYGRIS.
Clareo Health | TYSABRI Global Observational Program in Safety
